Skip to content

13F-HR filed by Monashee Investment Management LLC

Monashee Investment Management LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-09, with 41 holding rows worth $232,331,318.

Accession
0001172661-23-000559
Filed
2023-02-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 41 entries on the cover page, a total value of $232,331,318 stated on the cover page (in dollars after the unit check, H1), rows summing to $232,331,318 with VALUE read as dollars as filed, 13F file number 028-16854. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VTI922908769COM310,000$59,268,900dollars as filed
CHART INDS INC16115Q308COM100,000$11,523,000dollars as filed
COMPASS THERAPEUTICS INC20454B104COM2,230,441$11,219,000dollars as filed
CONSTELLATION BRANDS INC CL A21036P108Stock40,000$9,270,000dollars as filed
NOVAVAX INC670002AB0NOTE 3.750% 2/09,000,000$9,086,805dollars as filedprincipal
ALIGHT INC01626W101COM CL A979,397$8,187,759dollars as filed
CHART INDS INC16115Q4076.75DP CNV PFD B150,000$7,596,450dollars as filed
CENCORA INC COM03073E105Stock45,000$7,456,950dollars as filed
PATRICK INDS INC703343AB9DBCV 1.000% 2/07,000,000$6,987,797dollars as filedprincipal
RINGCENTRAL INC76680RAF4NOTE 3/08,000,000$6,919,840dollars as filedprincipal
LAUREATE ED INC COMMON STOCK518613203Stock698,304$6,717,684dollars as filed
INVESCO QQQ TR46090E103COM25,000$6,657,000dollars as filed
ASPEN AEROGELS INC04523Y105COMMON STOCK505,000$5,953,950dollars as filed
SUPERNUS PHARMACEUTICALS868459AD0BOND6,000,000$5,914,455dollars as filedprincipal
OKTA INC679295AD7NOTE 0.125% 9/06,000,000$5,310,160dollars as filedprincipal
HERBALIFE NUTRITION LTD42703MAD5NOTE 2.625% 3/15,000,000$4,672,846dollars as filedprincipal
AN2 THERAPEUTICS INC037326105COM450,000$4,288,500dollars as filed
THERAVANCE INC88338TAB0CORPORATE OBLIG4,000,000$4,034,394dollars as filedprincipal
NEW RELIC INC64829BAB6NOTE 0.500% 5/04,000,000$3,934,333dollars as filedprincipal
SPLUNK INC848637AC8NOTE 0.500% 9/14,000,000$3,872,089dollars as filedprincipal
ROIVANT SCIENCES LTDG76279101SHS470,000$3,755,300dollars as filed
NEW FORTRESS ENERGY INC644393100COM CL A87,700$3,720,234dollars as filed
WIX COM LTD92940WAB5NOTE 7/03,000,000$2,920,440dollars as filedprincipal
PLIANT THERAPEUTICS INC729139105COM150,000$2,899,500dollars as filed
WESTERN DIGITAL CORP.958102AP0NOTE 1.500% 2/03,000,000$2,887,530dollars as filedprincipal
BIOHAVEN LTDG1110E107COM200,000$2,776,000dollars as filed
RAIN ONCOLOGY INC75082Q105COM314,171$2,513,368dollars as filed
SOMALOGIC INC83444K105COM1,000,000$2,510,000dollars as filed
CRESCENT ENERGY COMPANY CL A COM44952J104Stock175,000$2,098,250dollars as filed
INDIE SEMICONDUCTOR INC45569U101CLASS A COM350,000$2,040,500dollars as filed
BELLUS HEALTH INC NEW07987C204COM245,000$2,013,900dollars as filed
ILLUMINA INC452327AK5NOTE 8/12,000,000$1,935,600dollars as filedprincipal
RAPID7 INC753422AD6NOTE 2.250% 5/02,000,000$1,933,380dollars as filedprincipal
KARYOPHARM THERAPEUTICS INC48576U106COM481,696$1,637,766dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock123,719$1,433,903dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK131,640$1,382,220dollars as filed
8X8 INC NEW282914AB6BOND1,500,000$1,352,645dollars as filedprincipal
TERNS PHARMACEUTICALS INC COM880881107Stock122,500$1,247,050dollars as filed
FREYR BATTERYL4135L100SHS125,000$1,085,000dollars as filed
AERSALE CORPORATION00810F106COM42,344$686,820dollars as filed
PROFRAC HLDG CORP74319N100CLASS A COM25,000$630,000dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-23-000559this filing2023-02-09acceptance time not in the bulk data set